News in Brief
Pharmacology - Sep 19
Novartis presents new Kisqali data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
Novartis presents new Kisqali data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
Research Management - Sep 17
Horizon Europe: Federal Council submits transitional measures to Parliament for non-accessible programme components
Horizon Europe: Federal Council submits transitional measures to Parliament for non-accessible programme components
Pharmacology - Sep 17
Novartis announces findings from a real-world study of alpelisib demonstrating clinical benefit in people with PIK3CA-Related Overgrowth Spectrum (PROS)
Novartis announces findings from a real-world study of alpelisib demonstrating clinical benefit in people with PIK3CA-Related Overgrowth Spectrum (PROS)
wire - news in brief
Category
Results 351 - 400 of 411.
Biomedical research without boundaries
In autumn 2021 a new biomedical reseach centre will be inaugurated in Bellinzona. To support this event, Ticino Management is running a special series of articles presenting the activities of the two main residents of the facility, IRB and IOR.
In autumn 2021 a new biomedical reseach centre will be inaugurated in Bellinzona. To support this event, Ticino Management is running a special series of articles presenting the activities of the two main residents of the facility, IRB and IOR.
Roche purchases shares in tender offer for GenMark Diagnostics, Inc
Basel, 22 April 2021 - Roche and GenMark Diagnostics, Inc. today announced that Roche's wholly owned subsidiary Geronimo Acquisition Corp.
Basel, 22 April 2021 - Roche and GenMark Diagnostics, Inc. today announced that Roche's wholly owned subsidiary Geronimo Acquisition Corp.
Science advice is crucial
The scientific community is taking a clear stand on the CO2 Act. Given their expertise, they are not only permitted, but obliged to do so, asserts Reto Knutti.
The scientific community is taking a clear stand on the CO2 Act. Given their expertise, they are not only permitted, but obliged to do so, asserts Reto Knutti.
The national innovation platform Switzerland Innovation is expanding in Eastern Switzerland with its latest addition, the Innovation Park East.
EPFL spin-off Readily3D has developed a novel system that can print biological tissue in just 30 seconds.
Since 15 April, it is official: The Technology Transfer Center for 3D Printing in Medical Technology - Swiss m4m Center, in short - meets the requirements of ISO standard 13485:2016; it is thus allowed to produce implants and instruments for human patients.
Europe’s largest capacity research centrifuge
The most capable geotechnical research centrifuge in Europe is currently being built on the Hönggerberg campus.
The most capable geotechnical research centrifuge in Europe is currently being built on the Hönggerberg campus.
A team of EPFL scientists has studied the behavior of defects on 2D crystals in water in order to better understand the crystals' properties and assess their quality.
Obituary: Dr. Reinhard Glück
We are deeply saddened to learn of the unexpected passing of Dr. Reinhard Glück. He passed away unexpectedly on Sunday, 19 April, 2021, shortly before reaching the age of 70.
We are deeply saddened to learn of the unexpected passing of Dr. Reinhard Glück. He passed away unexpectedly on Sunday, 19 April, 2021, shortly before reaching the age of 70.
During the winter months, renewable energy is in short supply throughout Europe. An international project is now considering an unconventional solution: Renewable hydrogen and carbon dioxide are pumped into the ground together, where naturally occurring microorganisms convert the two substances into methane, the main component of natural gas.
New Measure to Predict Stress Resilience
Researchers at the University of Zurich show that increased sensitivity in a specific region of the brain contributes to the development of anxiety and depression in response to real-life stress. Their study establishes an objective neurobiological measure for stress resilience in humans. Some people don't seem to be too bothered when it comes to handling stress.
Researchers at the University of Zurich show that increased sensitivity in a specific region of the brain contributes to the development of anxiety and depression in response to real-life stress. Their study establishes an objective neurobiological measure for stress resilience in humans. Some people don't seem to be too bothered when it comes to handling stress.
Empa researchers have analyzed the entire material and energy flows of the Swiss economy. Their final report now provides important data and comparisons. The team also looked into how the behavior of the Swiss population affects greenhouse gas emissions. Buildings, industrial plants, roads, cars, gasoline, electricity and all our consumption: What does Switzerland consume each year?
The end of the pandemic is still not in sight, but we have every reason to be hopeful. How has the first year of living with the virus changed ETH? And what will endure after the crisis ends? I only briefly experienced what ETH was like before the pandemic.
At NEST, the research and innovation platform of Empa and Eawag, the new Sprint unit is currently under construction - an office unit built largely from recycled materials.
A mobile handwashing station that hygienically recycles its own water without water mains or sewage connection not only has great potential for deployment in countries lacking in infrastructure.
Researchers show that foreign companies are less likely to have their patent applications granted in China than their Chinese counterparts.
Researchers show that foreign companies are less likely to have their patent applications granted in China than their Chinese counterparts, and point out that this discrimination occurs in technologies of strategic importance to the Chinese government: the telecommunication and biotech industries.
Why study biodiversity? Because we depend on it!
In the Blue-Green Biodiversity research initiative of WSL and Eawag scientists from around the world are working together to find solutions to the pressing challenges of biodiversity loss.
In the Blue-Green Biodiversity research initiative of WSL and Eawag scientists from around the world are working together to find solutions to the pressing challenges of biodiversity loss.
For many centuries, the people of southern Sumatra saw themselves as living on a ship floating between the sea and the heavens.
FMI: Congratulations to our fellowship winners
April 6, 2021 We are pleased to announce the latest FMI winners of prestigious research fellowships, including EMBO, Maria Sklodowska-Curie Actions (MSCA), Human Frontier Science Program (HFSP) and Boehringer Ingelheim Funds (BIF).
April 6, 2021 We are pleased to announce the latest FMI winners of prestigious research fellowships, including EMBO, Maria Sklodowska-Curie Actions (MSCA), Human Frontier Science Program (HFSP) and Boehringer Ingelheim Funds (BIF).
Bad news for allergy sufferers: The rising temperatures over the past three decades have impacted the onset, duration and intensity of the pollen season in Switzerland. These are the results of a study by the Swiss Tropical and Public Health Institute (Swiss TPH) in collaboration with the Federal Office of Meteorology and Climatology (MeteoSwiss).
An 80-metre-high skyscraper made of wood is soon to be built in Zug. A pioneering project for which basic research is being carried out in the construction hall on the Hönggerberg.
A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation
Roche launches Elecsys Epstein-Barr Virus (EBV) immunoassay panel to improve EBV infection staging
The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood sample, which means less confirmatory testing and, potentially, faster diagnosis for patients Clear and quick d
The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood sample, which means less confirmatory testing and, potentially, faster diagnosis for patients Clear and quick d
Many cocoa farmers live in poverty - yet the fairly traded chocolate bunny often stays on the shelves.
News in Brief
Pharmacology - Sep 19
Novartis presents new Kisqali data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
Novartis presents new Kisqali data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
Research Management - Sep 17
Horizon Europe: Federal Council submits transitional measures to Parliament for non-accessible programme components
Horizon Europe: Federal Council submits transitional measures to Parliament for non-accessible programme components
Pharmacology - Sep 17
Novartis announces findings from a real-world study of alpelisib demonstrating clinical benefit in people with PIK3CA-Related Overgrowth Spectrum (PROS)
Novartis announces findings from a real-world study of alpelisib demonstrating clinical benefit in people with PIK3CA-Related Overgrowth Spectrum (PROS)